The Generic Genetic (GG) Corporation pays no cash dividends currently and is not expected to for the next four years. Its latest EPS was $6.90, all of which was reinvested in the company. The firms expected ROE for the next four years is 26% per year, during which time it is expected to continue to reinvest all of its earnings. Starting in year 5, the firms ROE on new investments is expected to fall to 25% per year. GGs market capitalization rate is 25% per year. a. What is your estimate of GGs intrinsic value per share? (Round your answer to 2 decimal places.)